Evaluation of a Multi-electrode Prosthesis Control System for Real-world Tasks Performance in Individuals With Upper Limb Transradial Amputation

NCT ID: NCT07071584

Last Updated: 2025-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study tests how well the Phantom X prosthesis control system works. The system helps control a prosthetic hand using muscle signals from the arm. You'll wear a non-invasive version for one day in the clinic. You'll practice hand movements and then do two simple tasks with both your usual prosthesis and the Phantom X system. At the end, you'll fill out short surveys about your experience.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to evaluate the functional performance of the Phantom X prosthesis control system using a non-invasive version of its 32-electrode sensor array. All other components, including the Fusion Port, will be in their final clinical form factor, consistent with those used in future implantable configurations. The study will take place during a single, in-clinic session. Informed consent will be obtained either remotely prior to the visit or at the start of the session. Participants will undergo an initial EMG screening to determine signal suitability. Those with insufficient signal quality will be excluded. Eligible participants will be fitted with a universal socket, prosthesis, and the Phantom X system. Accelerometers will be placed on both limbs for movement tracking. Participants will practice a predefined set of gestures, followed by system calibration. Two validated functional assessments, Assessment of Capacity for Myoelectric Control (ACMC) and Targeted Box and Blocks Test (tBBT), will be conducted under two conditions: with the participant's baseline setup (if applicable) and with Phantom X. The testing order will be randomized. Participants will complete a user satisfaction questionnaire and NASA Task Load Index instrument to measure intuitiveness of Phantom X system before exiting the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Limb Amputation Below Elbow

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants instrumented with cutaneous version of Phantom X system using a universal socket

With Phantom X system instrumented, participants will perform the following two assessments: ACMC and tBBT. They will also complete user satisfaction and NASA-TLX questionaries.

Group Type EXPERIMENTAL

Cutaneous Prosthesis Control System

Intervention Type DEVICE

Prosthesis control system using a multi-electrode cutaneous sensor array

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cutaneous Prosthesis Control System

Prosthesis control system using a multi-electrode cutaneous sensor array

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Individuals 21 years in age and older
2. Individuals with unilateral or bilateral amputation at transradial level
3. Patient is willing to comply with study protocol and make required study visits
4. Willingness and ability to sign Informed Consent

Exclusion Criteria

1. Cognitively impaired to follow study instructions
2. Allergies to skin adhesive materials necessary for cutaneous electrode placement
3. Excessive hair growth on arms and inability to shave off the hair for electrode placement
4. Pregnant woman
5. Residual limbs of insufficient diameter or length to accommodate the wearing of two cutaneous sensor arrays
6. Injuries, bruises, or open wounds on the arm that needs to be instrumented for the study
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Atlas Ambulatory Surgery Center

UNKNOWN

Sponsor Role collaborator

Phantom Neuro Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elad Levy, MD

Role: PRINCIPAL_INVESTIGATOR

Atlas Ambulatory Surgery Center, Buffalo, NY

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Atlas Ambulatory Surgery Center

Buffalo, New York, United States

Site Status NOT_YET_RECRUITING

Phantom Neuro Inc. Operational Headquarters

Austin, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vinod Sharma, PhD

Role: CONTACT

17633502091

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elad Levy, MD

Role: primary

1 (716) 218-1000

Vinod Sharma, PhD

Role: primary

7633502091

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PN02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.